Jennifer Kathleen Bielasz, Sr.Dir. of Acct. & Cont. (PAO) at ARENA PHARMACEUTICALS INC (ARNA), bought 30 shares at $1.90 ($57) on 2012-02-01, disclosed to the SEC on 2012-02-07.
Open-market purchase of $57 ARNA by Sr.Dir. of Acct. & Cont. (PAO). Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.